Table 1.
Samples with | Boys | Girls | ||||||
---|---|---|---|---|---|---|---|---|
LOD | below LOD | (N = 106) | (N = 79) | |||||
(ppt) | N (%) | Median | GM | GSD | Median | GM | GSD | |
PCDD congeners (pg/g lipid) | ||||||||
2,3,7,8-TetraCDD | 0.004 | 11 (5.9) | 1.5 | 1.3 | 2.1 | 1.7 | 1.4 | 2.6 |
1,2,3,7,8-PentaCDD | 0.011 | 0 | 4.2 | 4.3 | 1.6 | 4.5 | 4.1 | 1.7 |
1,2,3,4,7,8-HexaCDD | 0.004 | 0 | 2.2 | 2.3 | 1.6 | 2.4 | 2.3 | 1.7 |
1,2,3,6,7,8-HexaCDD | 0.01 | 0 | 8.3 | 8.2 | 1.6 | 8.4 | 8.2 | 1.8 |
1,2,3,7,8,9-HexaCDD | 0.008 | 0 | 2.5 | 2.6 | 1.6 | 2.7 | 2.7 | 1.7 |
1,2,3,4,6,7,8-HeptaCDD | 0.008 | 0 | 12.1 | 12.0 | 1.5 | 11.4 | 12.1 | 1.6 |
OctaCDD | 0.008 | 0 | 63.9 | 67.7 | 1.5 | 68.1 | 67.7 | 1.6 |
PCDF congeners (pg/g lipid) | ||||||||
2,3,7,8-TetraCDF | 0.005 | 13 (7.0) | 0.5 | 0.5 | 2.0 | 0.6 | 0.5 | 2.2 |
1,2,3,7,8-PentaCDF | 0.006 | 0 | 1.2 | 1.2 | 1.7 | 1.3 | 1.2 | 2.1 |
2,3,4,7,8-PentaCDF | 0.01 | 0 | 7.2 | 7.1 | 1.5 | 8.1 | 7.2 | 1.7 |
1,2,3,4,7,8-HexaCDF | 0.008 | 0 | 16.5 | 16.7 | 1.6 | 19.9 | 18.0 | 1.9 |
1,2,3,6,7,8-HexaCDF | 0.003 | 0 | 10.8 | 10.2 | 1.6 | 12.0 | 11.1 | 1.9 |
1,2,3,7,8,9-HexaCDF | 0.004 | 12 (13.5) | 0.2 | 0.2 | 2.2 | 0.3 | 0.3 | 2.7 |
2,3,4,6,7,8-HexaCDF | 0.006 | 0 | 1.3 | 1.2 | 1.5 | 1.5 | 1.4 | 1.9 |
1,2,3,4,6,7,8-HeptaCDF | 0.01 | 0 | 10.8 | 11.6 | 1.6 | 13.5 | 12.9 | 2.0 |
1,2,3,4,7,8,9-HeptaCDF | 0.004 | 3 (1.6) | 1.2 | 1.1 | 1.9 | 1.6 | 1.2 | 2.7 |
OctaCDF | 0.013 | 47 (25.4) | 0.5 | 0.6 | 2.4 | 0.5 | 0.6 | 2.6 |
TEQs (pg-TEQ/g lipid) | ||||||||
TEQ-PCDDs | 7.4 | 7.3 | 1.6 | 8.0 | 7.3 | 1.8 | ||
TEQ-PCDFs | 5.2 | 5.3 | 1.5 | 5.7 | 5.6 | 1.8 | ||
TEQ-PCDDs/Fs | 12.5 | 12.6 | 1.5 | 14.2 | 13.0 | 1.7 |
CDD chlorinated dibenzo-p-dioxin, CDF chlorinated dibenzofuran, GM geometrical mean, GSD geometrical standard deviation, LOD limit of detection, PCDD polychlorinated dibenzo-p-dioxin, PCDF polychlorinated dibenzofuran, ppt parts per trillion, TEQ toxic equivalency